CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 507475-507605 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T93240","span":{"begin":0,"end":130},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, therapeutic administration of E6070 in PLP (proteolipid protein)-induced EAE model showed decreased disease severity."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T75","span":{"begin":0,"end":130},"obj":"Sentence"}],"text":"Furthermore, therapeutic administration of E6070 in PLP (proteolipid protein)-induced EAE model showed decreased disease severity."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1126","span":{"begin":86,"end":89},"obj":"Phenotype"}],"attributes":[{"id":"A1126","pred":"hp_id","subj":"T1126","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"Furthermore, therapeutic administration of E6070 in PLP (proteolipid protein)-induced EAE model showed decreased disease severity."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3250","span":{"begin":86,"end":89},"obj":"Disease"},{"id":"T81352","span":{"begin":86,"end":89},"obj":"Disease"}],"attributes":[{"id":"A3250","pred":"mondo_id","subj":"T3250","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A3251","pred":"mondo_id","subj":"T3250","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A3252","pred":"mondo_id","subj":"T3250","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A35128","pred":"mondo_id","subj":"T81352","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A6267","pred":"mondo_id","subj":"T81352","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A85255","pred":"mondo_id","subj":"T81352","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"}],"text":"Furthermore, therapeutic administration of E6070 in PLP (proteolipid protein)-induced EAE model showed decreased disease severity."}